Polar Asset Management Partners’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Polar Asset Management Partners’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-637,175	Closed	-$13.6M	–	1599
2021 Q4	$13.6M	Sell	637,175 -1,060,032	-62%	-$20.9M	0.14%	167
2021 Q3	$31.4M	Buy	1,697,207 +422,011	+33%	+$8.5M	0.31%	59
2021 Q2	$27.3M	Buy	1,275,196 +746,405	+141%	+$15.2M	0.28%	75
2021 Q1	$10.2M	Buy	+528,791	New	+$9.32M	0.1%	187

Other funds holding OCDX

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Polar Asset Management Partners's OCDX Position: Q1 2022 in Review

Polar Asset Management Partners sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 637,175 shares — an estimated $13.6M sold.

Polar Asset Management Partners first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $31.4M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

Polar Asset Management Partners reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Polar Asset Management Partners sold 637,175 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $13.6M.
Polar Asset Management Partners first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
Polar Asset Management Partners's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $31.4M in Q3 2021.
170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Polar Asset Management Partners's 13F filing for Q1 2022, filed 16 May 2022.